Finished
MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention
NCT05544409 · MarsiBionics · Updated 16 Sept 2022
- What is being tested
- MAKv1
- For
- Total Knee Arthroplasty
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 6 people. The full rules are on the registry page.
- Where
- Spain
- When
- Starts or started 12 June 2019, ends 8 Feb 2021. Registered 16 Sept 2022.
- Results
- None posted yet.
In the researchers' words
The present study analyzes the effects of using a portable single limb exoskeleton (MAKv1) in patients with total knee artrhoplasty (TKA). Safety, usability and clinical effects of an early intervention program with the device with an early implementation are studied.
Sites
- Hozpital Universitario La ZarzuelaMadrid, Spain